2013 World Cutaneous Malignancies Congress Virtual Conference
![]() |
Part 1.World Cutaneous Malignancies Congress
SanJiv Arguwala, Jeffery Sosman
|
![]() |
Part 2. Tumor Growth and Development
Steven Nelson, Alain Rook
|
![]() |
Part 3. Etiology of “Spontaneous” and Drug-Induced Tumors
Jean Yuh Tong
|
![]() |
Part 4. Pathogenesis of Merkel Cell Carcimona: An Infectioner Etiology
Paul Nghiem
|
![]() |
Part 5. General Session II: Current Treatment Guidelines in Cutaneous Malignancies
Sanjiv Agarwala
|
![]() |
Part 6. Surgical Options for BCC & SCC
Ralph Massey, Paul Nghiem
|
![]() |
Part 7. Current Treatment Guidelines for Cutaneous T-Cell Lymphoma
Madeleine Duvic
|
![]() |
Part 8. Case Studies- Advanced BCC
Dirk Schadendorf, Christopher Bichakjim
|
![]() |
Part 9. Session III: Review of Prevention and Emerging Treatment Options for Cutaneous Malgnancies
Axel Hauschild, Steven O’Day
|
![]() |
Part 10. Emerging BCC Therapies: Challenges & Future Directions
Aleksander Sekulic- Shailender Bhatia
|
![]() |
Part 11. Emerging Treatment Options for CTCL
Pierluigi Porcu, Kurgen Becker
|
![]() |
Part 12. General Session IV: An Interdisciplining Approach to Patient Care
Maria Martins-Lopes
|
![]() |
Part 13. General Session V: What I learned at Recent Meetings
Alain Rook
|
![]() |
Part 14. What I learned at ASCO 2013
Sanjiv Argarwala
|
![]() |
Part 15. Panel Discussion
Panel Discussion
|
By continuing to browse this site, you agree to our
use of cookies.